|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2100052538 |
|
最近更新日期: Date of Last Refreshed on: |
2022-05-15 22:28:04 |
|
注册时间: Date of Registration: |
2021-10-30 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
新型无菌硅胶导尿管在临床中的应用:一项前瞻性随机对照研究 |
|
Public title: |
Clinical application of new silicone foley catheter: a randomized controlled trial |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
新型无菌硅胶导尿管在临床中的应用:一项前瞻性随机对照研究 |
|
Scientific title: |
Clinical application of new silicone foley catheter: a randomized controlled trial |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
李慢 |
研究负责人: |
蒋博 |
|
Applicant: |
Li Man |
Study leader: |
Jiang Bo |
|
申请注册联系人电话: Applicant telephone: |
+86 15801179390 |
研究负责人电话: Study leader's telephone: |
+86 13716753060 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
liman955190@126.com |
研究负责人电子邮件: Study leader's E-mail: |
963944231@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市怀柔区迎宾北路38号 |
研究负责人通讯地址: |
北京市怀柔区迎宾北路38号 |
|
Applicant address: |
38 Yingbin Road North, Huairou District, Beijing |
Study leader's address: |
38 Yingbin Road North, Huairou District, Beijing |
|
申请注册联系人邮政编码: Applicant postcode: |
101499 |
研究负责人邮政编码: Study leader's postcode: |
101499 |
|
申请人所在单位: |
首都医科大学附属北京妇产医院怀柔妇幼保健院 |
||
|
Applicant's institution: |
Huairou Maternal and Child Health Care Hospital, Beijing Obsterics and Gynecology Hospital, Capital Medical University |
||
|
研究负责人所在单位: |
首都医科大学附属北京妇产医院怀柔妇幼保健院 |
||
|
Affiliation of the Leader: |
Huairou Maternal and Child Health Care Hospital, Beijing Obsterics and Gynecology Hospital, Capital Medical University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
京怀妇伦字(2021)001号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
首都医科大学附属北京妇产医院怀柔妇幼保健院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Huairou Maternal and Child Health Care Hospital, Beijing Obsterics and Gynecology Hospital, Capital Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2021-10-10 00:00:00 |
||
|
伦理委员会联系人: |
田兴军 |
||
|
Contact Name of the ethic committee: |
Tian Xingjun |
||
|
伦理委员会联系地址: |
北京市怀柔区迎宾北路38号 |
||
|
Contact Address of the ethic committee: |
38 Yingbin Road North, Huairou District, Beijing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 10 89691500 8111 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
hrfyllwyh@163.com |
|
研究实施负责(组长)单位: |
首都医科大学附属北京妇产医院怀柔妇幼保健院 |
||||||||||||||||||||||
|
Primary sponsor: |
Huairou Maternal and Child Health Care Hospital, Beijing Obsterics and Gynecology Hospital, Capital Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市怀柔区迎宾北路38号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
38 Yingbin Road North, Huairou District, Beijing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
首都医科大学附属北京妇产医院怀柔妇幼保健院 |
||||||||||||||||||||||
|
Source(s) of funding: |
Huairou Maternal and Child Health Care Hospital, Beijing Obsterics and Gynecology Hospital, Capital Medical University |
||||||||||||||||||||||
|
Target disease: |
catheterization |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
新型无菌硅胶导尿管与传统一次性导尿管在剖宫产手术留置术中的优势与效果。 |
||||||||||||||||||||||
|
Objectives of Study: |
Comparative study on clinical effect of new silicone foley catheter and traditional catheter. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.选择产科分娩孕妇; |
||||||||||||||||||||||
|
Inclusion criteria |
1. Select the pregnant women who delivered in the hospital; |
||||||||||||||||||||||
|
排除标准: |
1.存在医疗纠纷或者护理隐患的产妇; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. The pregnant women who had medical dispute or nursing risks; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2021-08-01 00:00:00至 To 2022-07-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2021-11-01 00:00:00 至 To 2022-02-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由课题组统计老师使用随机数字表产生随机序列. |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The random sequence will be generated by the statistical teacher using the random number table method. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不共享原始数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Not sharing IPD |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
EXCEL表记录了受试者的随机分配的ID.电子数据存在SPSS里. |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
EXCEL recorded subjects' ID. Electronic data is kept in SPSS. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |